At site of bone resorption (Figure 8), the activation by Ca2+ of the CaSR expressed by metastatic breast cancer cells favors epiregulin synthesis and secretion, which in turn acts on osteoblastic cells to reduce OPG synthesis. Here, CASR is linked to breast carcinoma.